Connecting Cancer Research Unicorns

Every year, millions of medical studies are published, however most of that knowledge stays locked away in scattered journals and databases. Doctors and researchers looking for answers face huge barriers:

• Insights are buried in thousands of separate papers.
• Traditional searches miss vital connections between discoveries.
• Access costs and delays mean life-saving findings don’t always reach the people who need them.

For families fighting rare childhood cancers like hepatoblastoma, this is more than a technical problem — it’s a matter of life and death. When research is lost in the noise, children lose chances at better treatments.

 The Fartsicorn Foundation is building OncoMap AI, a breakthrough platform that uses artificial intelligence to bring the world’s cancer research together in one place.

Instead of spending months searching through thousands of studies, doctors will be able to ask OncoMap AI a question and instantly surface insights that could guide treatments.

Here’s what makes it different:

• Smarter search: OncoMap AI “understands” concepts, not just keywords — so it can connect the dots that humans or traditional tools often miss.
• Hidden breakthroughs revealed: The AI links discoveries across different cancers and genetic pathways, showing possibilities that might otherwise never come to light.
• Trustworthy answers: Every response comes backed by published research, so clinicians know they can rely on the evidence.

This project isn’t just about building new technology — it’s about giving hope.

• Faster answers for doctors: Helping them find the best options for their patients.
• Equal access: Leveling the playing field so even small hospitals and clinics can access cutting-edge insights.
• More chances for children: Turning buried research into real treatments for kids facing rare, devastating diseases.
• Open access: as a not-for-profit, Fartsicorn is about making the information as widely available as possible-- unbound by the need for profit and returns.

As Prof Paul Glasziou, Emeritus Professor at the prestigious Bond University in Australia has put it: without accessible research, patients and families cannot benefit. OncoMap AI exists to change that — but we need your help to make it real.

Source: https://research.bond.edu.au/en/publications/avoidable-waste-in-the-production-and-reporting-of-research-evide-3)